Serum free IgE guided dose reduction of omalizumab: a case report

BACKGROUND: Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that is used for severe asthma patients who are allergic to perenn...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Allergy Asthma Clin Immunol
Hlavní autoři: Gon, Yasuhiro, Ito, Reiko, Maruoka, Shuichiro, Mizumura, Kenji, Kozu, Yutaka, Hiranuma, Hisato, Iida, Yuko, Shikano, Sotaro, Hashimoto, Shu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5577842/
https://ncbi.nlm.nih.gov/pubmed/28861109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-017-0211-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky